MedPath

Laparoscopic Gastrectomy for Advanced Gastric Cancer

Phase 2
Completed
Conditions
Laparoscopic Gastrectomy
Advanced Gastric Cancer
Interventions
Procedure: Laparoscopic gastrectomy
Registration Number
NCT01441336
Lead Sponsor
Seoul National University Bundang Hospital
Brief Summary

Although laparoscopic gastrectomy (LG) is widely used for the treatment of early gastric cancer, there have been few reports of the efficacy of LAG in the management of advanced gastric cancer(AGC). The aim of this study is to evaluate the surgical outcomes and oncologic safety of laparoscopic gastrectomy for AGC.

Detailed Description

Prospective phase II clinical trial to evaluate technical and oncological safety of LG for AGC

LG procedure for AGC:

D2 lymphadenectomy Total omentectomy for tumor with serosa exposure under laparoscopic exploration

Primary end point: 3 year disease free survival secondary end point: postoperative outcomes, morbidity and mortality, 3,5 and 7 year overall survival, Quality of life, recurrence pattern

Study duration: 7 years(enrollment: 4year, follow-up: 3year)

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
204
Inclusion Criteria
  • Age 20-80
  • informed consent
  • no other malignancies
  • cT2N0-cT3N2 according to JGCA 2nd edition
  • ASA score<3
Read More
Exclusion Criteria
  • distant metastasis(P1 or M1) under laparoscopic exploration
  • Conglomerated N2
  • early gastric cancer in permanent pathologic report
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Laparoscopic gastrectomyLaparoscopic gastrectomyLaparoscopic gastrectomy procedure: D2 lymphadenectomy \& total omentectomy in case of tumor with serosa exposure under laparoscopic exploration
Primary Outcome Measures
NameTimeMethod
3 year recurrence free survivalPostoperative 3 year

Evaluation of recurrence after regular 3 months follow-up using tumor marker, chest x-ray, endoscopy and computed tomograhy.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Seoul National University Bundang Hospital

🇰🇷

Seongnam, Gyeonggi, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath